Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation

被引:355
作者
Wolf, RK
Schneeberger, EW
Osterday, R
Miller, D
Merrill, W
Flege, JB
Gillinov, AM
机构
[1] Univ Cincinnati, Coll Med, Sect Cardiothorac Surg, Cincinnati, OH 45267 USA
[2] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA
关键词
D O I
10.1016/j.jtcvs.2005.03.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Pulmonary vein isolation is curative in selected patients with atrial fibrillation. The objective of this study was to assess the feasibility and safety (midterm results) of video-assisted thoracoscopic epicardial pulmonary vein isolation. Methods: Twenty-seven patients (22 male patients) with atrial fibrillation (18 paroxysinal, 4 persistent, and 5 permanent; average age, 57 years) underwent bilateral video-assisted thoracoscopic off-pump epicardial pulmonary vein isolation and exclusion of the left atrial appendage. All patients had had unsuccessful drug therapy or were intolerant to antiarrhythmic drug therapy or were intolerant to warfarin. The approach included two 10-mm ports and one 5-cm working port (non-rib spreading) bilaterally. Pulmonary vein isolation was achieved bilaterally by using a bipolar radiofrequency device. The left atrial appendage was excised with a surgical stapler. Results: Bilateral pulmonary vein isolation and left atrial appendage excision was performed successfully in all patients. There were no conversions to sternotomy or thoracotomy. All patients were extubated in the operating room. Postoperative complications in 3 patients were minor and resolved within 48 hours. One morbidly obese patient had more serious complications related to comorbid conditions. Average postoperative follow-up is approximately 6 months (173.6 days). Twenty-three patients have been followed up for greater than 3 months, and 21 of these patients are free of atrial fibrillation (91.3%). The results of magnetic resonance angiography were normal (no pulmonary vein stenosis) in 12 of 12 patients evaluated 3 to 6 months postoperatively. Conclusions: Bilateral video-assisted thoracoscopic pulmonary vein isolation with excision of the left atrial appendage is feasible and safe and offers a promising, new, minimally invasive, beating-heart approach for curative surgical treatment of atrial fibrillation.
引用
收藏
页码:797 / 802
页数:6
相关论文
共 30 条
[1]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[2]   Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation [J].
Cappato, R ;
Negroni, S ;
Pecora, D ;
Bentivegna, S ;
Lupo, PP ;
Carolei, A ;
Esposito, C ;
Furlanello, F ;
De Ambroggi, L .
CIRCULATION, 2003, 108 (13) :1599-1604
[3]   Ablation with an internally irrigated radiofrequency catheter: Learning how to avoid steam pops [J].
Cooper, JM ;
Sapp, JL ;
Tedrow, U ;
Pellegrini, CP ;
Robinson, D ;
Epstein, LM ;
Stevenson, WG .
HEART RHYTHM, 2004, 1 (03) :329-333
[4]  
Cox J L, 2000, Semin Thorac Cardiovasc Surg, V12, P15
[5]   SERIAL ANTIARRHYTHMIC DRUG-TREATMENT TO MAINTAIN SINUS RHYTHM AFTER ELECTRICAL CARDIOVERSION FOR CHRONIC ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER [J].
CRIJNS, HJ ;
VANGELDER, IC ;
VANGILST, WH ;
HILLEGE, H ;
GOSSELINK, AM ;
LIE, KI .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04) :335-341
[6]   Alternative energy sources for atrial ablation: Judging the new technology [J].
Damiano, RJ .
ANNALS OF THORACIC SURGERY, 2003, 75 (02) :329-330
[7]   Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? [J].
Doll, N ;
Borger, MA ;
Fabricius, A ;
Stephan, S ;
Gummert, J ;
Mohr, FW ;
Hauss, J ;
Kottkamp, H ;
Hindricks, G .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) :836-842
[8]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[9]   PROARRHYTHMIA IN PATIENTS TREATED FOR ATRIAL-FIBRILLATION OR FLUTTER [J].
FALK, RH .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :141-150
[10]   ANTIARRHYTHMIC DRUG-THERAPY AND CARDIAC MORTALITY IN ATRIAL-FIBRILLATION [J].
FLAKER, GC ;
BLACKSHEAR, JL ;
MCBRIDE, R ;
KRONMAL, RA ;
HALPERIN, JL ;
HART, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (03) :527-532